Exclusive

Publication

Byline

Singapore Clinical Trial: A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden (AFB) as well as the safety, tolerability, and pharmacokinetics of oral PKN605 in participants with atrial fibrillation

Singapore, April 12 -- The Health Sciences Authority received information related to the study titled 'A randomized, placebo-controlled, participant- and investigator-blinded study to evaluate the eff... Read More


Singapore Clinical Trial: A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Patients with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Singapore, April 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 2/3 Randomized Study to Evaluate the Safety, Efficacy, and Optimal Dose of Telisotuzumab ... Read More


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, April 12 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... Read More


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, April 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... Read More


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, April 12 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate... Read More


TDS on bank interest explained: Who is liable and how much gets deducted under new income tax rules?

New Delhi, April 12 -- With the Income Tax Act, 2025 coming into effect on April 1, the Income Tax Department clarified whether the eligibility criteria for the TDS threshold on bank interest has unde... Read More


Record turnout in Hungary as voters weigh change against Orban's rule

France, April 12 -- Opinion polls suggest the Tisza party of pro-European conservative Peter Magyar - who has promised a "system change" - is running well ahead of Orban's Fidesz. Orban, 62, who... Read More


CSK vs DC: Tristan Stubbs Glove Controversy Escalates, as Nitish Rana, Coach Hemang Badani Clash with Umpires | IPL 2026 Match 18

India, April 12 -- Delhi Capitals suffered their second consecutive loss as Chennai Super Kings defeated them by 23 runs to register their first win of the Indian Premier League 2026 season. Rain stay... Read More


Doctors to challenge Bihar govt's private practice ban in court

PATNA, April 12 -- Government doctors in Bihar have decided to challenge the state government's move to impose a blanket ban on private practice by allopathic doctors in the public sector, officials o... Read More


Countdown for new Bihar govt begins with last cabinet meet on April 14

PATNA, April 12 -- The countdown for the formation of a new government with a first-ever chief minister in Bihar has begun, as Nitish Kumar is set to tender his resignation and the shifting of his res... Read More